Kenvue Inc. $KVUE Shares Acquired by Financiere des Professionnels Fonds d investissement inc.

Financiere des Professionnels Fonds d investissement inc. raised its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 13.4% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 465,660 shares of the company’s stock after buying an additional 55,050 shares during the period. Financiere des Professionnels Fonds d investissement inc.’s holdings in Kenvue were worth $7,558,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Generali Asset Management SPA SGR boosted its stake in shares of Kenvue by 3.9% during the 3rd quarter. Generali Asset Management SPA SGR now owns 156,915 shares of the company’s stock worth $2,547,000 after acquiring an additional 5,843 shares in the last quarter. Salomon & Ludwin LLC purchased a new stake in shares of Kenvue during the third quarter valued at $25,000. Mather Group LLC. boosted its position in shares of Kenvue by 144.9% in the 3rd quarter. Mather Group LLC. now owns 30,169 shares of the company’s stock valued at $490,000 after purchasing an additional 17,849 shares during the period. Renaissance Capital LLC increased its stake in Kenvue by 55.8% in the 3rd quarter. Renaissance Capital LLC now owns 980,436 shares of the company’s stock worth $15,912,000 after purchasing an additional 351,259 shares in the last quarter. Finally, Perigon Wealth Management LLC boosted its holdings in shares of Kenvue by 13.5% in the third quarter. Perigon Wealth Management LLC now owns 18,316 shares of the company’s stock worth $297,000 after buying an additional 2,185 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analysts Set New Price Targets

KVUE has been the topic of several recent analyst reports. JPMorgan Chase & Co. cut their target price on shares of Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a research note on Friday, October 10th. Edward Jones downgraded Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 3rd. Jefferies Financial Group decreased their price objective on Kenvue from $25.00 to $23.00 and set a “buy” rating for the company in a research report on Monday, October 27th. The Goldman Sachs Group dropped their target price on Kenvue from $22.00 to $19.00 and set a “neutral” rating on the stock in a report on Thursday, October 2nd. Finally, Redburn Partners set a $22.00 price target on shares of Kenvue in a research report on Friday, September 26th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and twelve have issued a Hold rating to the company. Based on data from MarketBeat, Kenvue currently has a consensus rating of “Hold” and an average target price of $20.23.

Kenvue Price Performance

Shares of KVUE opened at $17.30 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. The firm has a market cap of $33.15 billion, a PE ratio of 23.07 and a beta of 0.60. The firm’s 50 day moving average price is $16.66 and its 200 day moving average price is $18.58. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $25.17.

Kenvue (NYSE:KVUE) last posted its earnings results on Monday, November 3rd. The company reported $0.28 EPS for the quarter, topping the consensus estimate of $0.27 by $0.01. The company had revenue of $3.76 billion during the quarter, compared to the consensus estimate of $3.83 billion. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The company’s revenue for the quarter was down 3.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.28 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, research analysts expect that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th were given a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, November 12th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.8%. Kenvue’s payout ratio is currently 110.67%.

Insider Activity

In related news, Director Jeffrey C. Smith acquired 3,200,000 shares of the stock in a transaction dated Friday, December 12th. The shares were acquired at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the acquisition, the director owned 27,307,632 shares in the company, valued at approximately $474,333,567.84. The trade was a 13.27% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.68% of the company’s stock.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.